← Leaderboards
Daniel F Martin
Jaeb Center For Health Research, Inc.
$22,866,677
Attributed
$63,017,426
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.5M · FY2006–25$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$63,017,426 · 3
By mechanism
UG1$60,226,123 · 1
U10$1,912,096 · 1
M01$879,207 · 1
Top collaborators
- Adam R Glassman7 shared
- Jennifer Katherine Sun7 shared
Most similar at Jaeb Center For Health Research, Inc.
Same institution · by research overlap
- Adam R Glassman$50,075,374
- Jennifer Katherine Sun$21,726,369
- Raymond Kraker$58,890,223
- Stacy Pineles$6,182,579
- Katherine K Weise$4,802,558
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsGrantDesignVisualUnited StatesAge Related Macular DegenerationBlindnessAmericanStandard Of CareReportingVisionResearch PersonnelRetinaClinical ResearchLeadershipFundingPublicationsPoliciesClinical TrialsBevacizumabMedicareAvastinMonoclonal AntibodiesNeovascular
Grant awards (19)
DRCR Retina Network$10,500,000
UG1 · FY2025 · EY
DRCR Retina Network$8,942,823
UG1 · FY2024 · EY
DRCR Network$4,650,478
UG1 · FY2023 · EY
DRCR Network$9,544,793
UG1 · FY2022 · EY
DRCR Network$9,588,029
UG1 · FY2021 · EY
DRCR Network$8,500,000
UG1 · FY2020 · EY
DRCR Network$8,500,000
UG1 · FY2019 · EY
Chair Grant for the Comparison for AMD Treatment Trials$163,393
U10 · FY2012 · EY · contact PI
Chair Grant for the Comparison for AMD Treatment Trials$104,394
U10 · FY2011 · EY · contact PI
Chair Grant for the Comparison of AMD Treatment Trials$899,828
U10 · FY2010 · EY · contact PI
Chair Grant for the Comparison for AMD Treatment Trials$52,008
U10 · FY2010 · EY · contact PI
Chair Grant for the Comparison of AMD Treatment Trials$137,008
U10 · FY2009 · EY · contact PI
Chair Grant for the Comparison of AMD Treatment Trials$132,950
U10 · FY2008 · EY · contact PI
Chair Grant for the Comparison of AMD Treatment Trials$37,684
U10 · FY2008 · EY · contact PI
Chair Grant for the Comparison of AMD Treatment Trials$189,091
U10 · FY2007 · EY · contact PI
Chair Grant for the Comparison of AMD Treatment Trials$195,740
U10 · FY2006 · EY · contact PI
ORAL VERSUS IV GANCICLOVIR IN CYTOMEGALOVIRUS RETINITIS$293,069
M01 · FY2002 · RR
ORAL VERSUS IV GANCICLOVIR IN CYTOMEGALOVIRUS RETINITIS$293,069
M01 · FY2002 · RR
ORAL VERSUS IV GANCICLOVIR IN CYTOMEGALOVIRUS RETINITIS$293,069
M01 · FY2001 · RR